Beth HAN

Dr. Beth HAN


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2017 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
BHBeth HAN
Beth HAN
WCWilson Compton
Wilson Compton
CBCarlos Blanco
Carlos Blanco
ECElizabeth Crane
Elizabeth Crane
JLJinhee Lee
Jinhee Lee
CJChristopher M. Jones
Christopher M. Jones
Despite the continuing epidemic of opioid misuse, data on the prevalence of prescription opioid use, misuse, and use disorders are limited. To estimate the prevalence of prescription opioid use, misuse, and use disorders and motivations for misuse among U.S. adults. Survey. The 2015 National Survey on Drug Use and Health (NSDUH). 72 600 eligible civilian, noninstitutionalized adults were selected for NSDUH, and 51 200 completed the survey interview. Prescription opioid use, misuse, and use disorders. Weighted NSDUH estimates suggested that, in 2015, 91.8 million (37.8%) U.S. civilian, noninstitutionalized adults used prescription opioids; 11.5 million (4.7%) misused them; and 1.9 million (0.8%) had a use disorder. Among adults with prescription opioid use, 12.5% reported misuse; of these, 16.7% reported a prescription opioid use disorder. The most commonly reported motivation for misuse was to relieve physical pain (63.4%). Misuse and use disorders were most commonly reported in adults who were uninsured, were unemployed, had low income, or had behavioral health problems. Among adults with misuse, 59.9% reported using opioids without a prescription, and 40.8% obtained prescription opioids for free from friends or relatives for their most recent episode of misuse. Cross-sectional, self-reported data. More than one third of U.S. civilian, noninstitutionalized adults reported prescription opioid use in 2015, with substantial numbers reporting misuse and use disorders. Relief from physical pain was the most commonly reported motivation for misuse. Economic disadvantage and behavioral health problems may be associated with prescription opioid misuse. The results suggest a need to improve access to evidence-based pain management and to decrease excessive prescribing that may leave unused opioids available for potential misuse. U.S. Department of Health and Human Services.

22 September 2021 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
BHBeth HAN
Beth HAN
WCWilson M. Compton
Wilson M. Compton
CJChristopher M. Jones
Christopher M. Jones
EEEmily B. Einstein
Emily B. Einstein
NVNora D. Volkow
Nora D. Volkow
In the US, overdose deaths involving psychostimulants with abuse potential other than cocaine (ie, largely methamphetamine) increased in the past decade1,2 more than doubling from 2.4 to 5.0 per 100 000 population from 2016 to 2019 alone.1 Furthermore, based on provisional mortality data, the estimated national number of these psychostimulant-associated overdose deaths increased 46% from 16 011 during November 2018 to October 2019 to 23 352 during November 2019 to October 2020.3

13 October 2015 in JAMA
Verified
Journal Article
Open access
PDF file
BHBeth HAN
Beth HAN
WCWilson M. Compton
Wilson M. Compton
CJChristopher M. Jones
Christopher M. Jones
RCRong Cai
Rong Cai
Since 1999, the United States has experienced increases in morbidity and mortality associated with nonmedical use of prescription opioids.1,2 During this period, emergency department (ED) visits and drug overdose deaths involving these drugs have increased rapidly.2-5 The prevalence of people aged 12 years or older who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for prescription opioid dependence increased from 0.4% in 2003 to 0.6% in 2013.6 Moreover, the estimated rates of ED visits involving prescription opioids more than doubled from 82.5 per 100 000 in 2004 to 184.1 per 100 000 in 2011.7 Furthermore, age-adjusted rates for drug-poisoning deaths involving prescription opioids more than tripled from 1.4 per 100 000 population in 1999 to 5.1 in 2013.8 Also in 2013, prescription opioids were involved in more deaths (>16 200) than all illicit drugs combined (14 775).8 Due to these increases in morbidity and mortality, prescription opioid abuse has become a US epidemic.2,9,10

12 December 2008 in Addiction
Verified
Journal Article
Closed access
PDF file
BHBeth HAN
Beth HAN
JGJoseph C. Gfroerer
Joseph C. Gfroerer
JCJames D. Colliver
James D. Colliver
MPMichael A. Penne
Michael A. Penne

1 June 2021 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
NVNora D. Volkow
Nora D. Volkow
BHBeth HAN
Beth HAN
EEEmily B. Einstein
Emily B. Einstein
WCWilson M. Compton
Wilson M. Compton
Earlier age at drug initiation has been shown to be associated with faster transition to substance use disorder (SUD).1 However, prevalence of specific SUDs as a function of time since first substance use among young people has not, to our knowledge, been investigated. We examined the prevalence of specific SUDs since first drug use (including tobacco, alcohol, cannabis, cocaine, methamphetamine, and heroin) or prescription misuse (including opioids, stimulants, and tranquilizers) in adolescents aged 12 to 17 years and young adults aged 18 to 25 years.

20 January 2021 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
BHBeth HAN
Beth HAN
JCJessica Cotto
Jessica Cotto
KEKathleen Etz
Kathleen Etz
EEEmily B. Einstein
Emily B. Einstein
WCWilson M. Compton
Wilson M. Compton
NVNora D. Volkow
Nora D. Volkow
US age-adjusted rates of drug overdose deaths involving methamphetamine increased nearly 5-fold during 2012-2018.1 Although addiction outcomes can be improved with sex-specific and culturally tailored prevention and treatment interventions, the extent to which fatalities differ as functions of sex and race and ethnicity has not been analyzed, to our knowledge.